Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis.

Ghimire S, Maharjan B, Jongedijk EM, Kosterink JGW, Ghimire GR, Touw DJ, van der Werf TS, Shrestha B, Alffenaar JC.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02379-18. doi: 10.1128/AAC.02379-18. Print 2019 May.

PMID:
30782999
2.

Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients.

Ghimire S, Maharjan B, Jongedijk EM, Kosterink JGW, Ghimire GR, Touw DJ, van der Werf TS, Shrestha B, Alffenaar JC.

Eur Respir J. 2019 Apr 18;53(4). pii: 1802107. doi: 10.1183/13993003.02107-2018. Print 2019 Apr. No abstract available.

PMID:
30655280
3.

First case reports of Ignatzschineria (Schineria) indica associated with myiasis.

Barker HS, Snyder JW, Hicks AB, Yanoviak SP, Southern P, Dhakal BK, Ghimire GR, Couturier MR.

J Clin Microbiol. 2014 Dec;52(12):4432-4. doi: 10.1128/JCM.02183-14. Epub 2014 Oct 8.

4.

Antimicrobial susceptibilities of enteric bacterial pathogens isolated in Kathmandu, Nepal, during 2002-2004.

Kansakar P, Baral P, Malla S, Ghimire GR.

J Infect Dev Ctries. 2011 Mar 21;5(3):163-8.

5.

Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.

Kansakar P, Malla S, Ghimire GR.

Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):32-7.

PMID:
18603983
6.

Going up in smoke.

Ghimire GR.

Kathmandu Univ Med J (KUMJ). 2004 Jul-Sep;2(3):180-1. No abstract available.

PMID:
16400210

Supplemental Content

Loading ...
Support Center